285 related articles for article (PubMed ID: 29710320)
1. Value-Based Pricing for Drugs: Theme and Variations.
Kaltenboeck A; Bach PB
JAMA; 2018 Jun; 319(21):2165-2166. PubMed ID: 29710320
[No Abstract] [Full Text] [Related]
2. Value-Based Pricing and Patient Access for Specialty Drugs.
Robinson JC; Howell S; Pearson SD
JAMA; 2018 Jun; 319(21):2169-2170. PubMed ID: 29801023
[No Abstract] [Full Text] [Related]
3. Prescription-drug coupons--no such thing as a free lunch.
Ross JS; Kesselheim AS
N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672
[No Abstract] [Full Text] [Related]
4. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs.
Cahn LJ
Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372
[No Abstract] [Full Text] [Related]
5. Copayment coupons undermine formularies.
Manag Care; 2011 Dec; 20(12):63. PubMed ID: 22259878
[No Abstract] [Full Text] [Related]
6. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
Sarpatwari A; Avorn J; Kesselheim AS
JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
[No Abstract] [Full Text] [Related]
7. Pharmaceuticals and Medical Devices: Cost Savings.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-31. PubMed ID: 29361657
[No Abstract] [Full Text] [Related]
8. Pharmaceuticals and Medical Devices: Cost Savings.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-31. PubMed ID: 30695849
[No Abstract] [Full Text] [Related]
9. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
Gudiksen KL; King JS
J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
[No Abstract] [Full Text] [Related]
10. Changes in Drug Pricing After Drug Shortages in the United States.
Hernandez I; Sampathkumar S; Good CB; Kesselheim AS; Shrank WH
Ann Intern Med; 2019 Jan; 170(1):74-76. PubMed ID: 30242373
[No Abstract] [Full Text] [Related]
11. Addressing Pharmaceutical Price Spikes Through Generic Preclearance.
Sachs RE
J Leg Med; 2019; 39(2):169-176. PubMed ID: 31503530
[No Abstract] [Full Text] [Related]
12. [The new reference prices: an opportunity for efficient management of medication].
Ausejo Segura M
Aten Primaria; 2005 Feb; 35(2):64-6. PubMed ID: 15727746
[No Abstract] [Full Text] [Related]
13. The Economics of Indication-Based Drug Pricing.
Chandra A; Garthwaite C
N Engl J Med; 2017 Jul; 377(2):103-106. PubMed ID: 28700848
[No Abstract] [Full Text] [Related]
14. Americans' access to prescription drugs stabilizes, 2007-2010.
Boukus ER; Carrier ER
Track Rep; 2011 Dec; (27):1-5. PubMed ID: 22180943
[TBL] [Abstract][Full Text] [Related]
15. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
Pavenik N
Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
[TBL] [Abstract][Full Text] [Related]
16. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
Mendoza RL
J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
[TBL] [Abstract][Full Text] [Related]
17. The scandal of generic drug pricing: drug regulation policies need review.
Meeran K; Choudhury SM; Wass J
BMJ; 2017 Feb; 356():j947. PubMed ID: 28232321
[No Abstract] [Full Text] [Related]
18. Prescription drug prices in the US.
Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
[No Abstract] [Full Text] [Related]
19. Pharmaceuticals and medical devices: FDA oversight.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
[No Abstract] [Full Text] [Related]
20. How to reduce out-of-pocket costs for prescription medications.
Eliason MJ; Sontheimer RD
Dermatol Online J; 2015 Jun; 21(6):. PubMed ID: 26158357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
